About the Authors
- David J. Rickard
-
* E-mail: David.J.Rickard@gsk.com
Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- Clark A. Sehon
-
Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- Viera Kasparcova
-
Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- Lorena A. Kallal
-
Affiliation Biological Reagents and Assay Development, Platform Technology Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- Xin Zeng
-
Affiliation Screening and Compound Profiling, Platform Technology Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- Monica N. Montoute
-
Affiliation Screening and Compound Profiling, Platform Technology Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- Tushar Chordia
-
Affiliation Biological Reagents and Assay Development, Platform Technology Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- Derek D. Poore
-
Affiliation Biological Reagents and Assay Development, Platform Technology Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- Hu Li
-
Affiliation Biological Reagents and Assay Development, Platform Technology Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- Zining Wu
-
Affiliation Screening and Compound Profiling, Platform Technology Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- Patrick M. Eidam
-
Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- Pamela A. Haile
-
Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- Jong Yu
-
Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- John G. Emery
-
Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- Robert W. Marquis
-
Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- Peter J. Gough
-
Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- John Bertin
-
Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: DJR CAS VK LAK XZ HL ZW PME JY JGE PJG JJB. Performed the experiments: DJR VK XZ MNM TC DDP JY. Analyzed the data: DJR CAS VK LAK XZ MNM TC DDP HL ZW PME PAH JGE RWM PJG JJB. Contributed reagents/materials/analysis tools: CAS PME PAH RWM. Wrote the paper: DJR CAS VK PJG JJB.